Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis

Cochrane Database Syst Rev. 2020 Jul 9;7(7):CD005160. doi: 10.1002/14651858.CD005160.pub3.

Authors

Rocco Orlando¹, Lorenzo Azzalini², Serena Orando³, Flavio Lirussi⁴

Affiliations

¹ Department of Medical and Surgical Sciences, University of Padua Medical School, Padova, Italy.
² -, Spain.
³ Valeggio sul Mincio, Italy.
⁴ WHO European Office for Investment for Health and Development, Venice, Italy.

Abstract

The review is withdrawn on 09.07.2020, as it has not been updated since its first publication in 2007.

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Publication types

Meta-Analysis
Systematic Review

MeSH terms

Bile Acids and Salts / therapeutic use*
Cholagogues and Choleretics / therapeutic use*
Fatty Liver / drug therapy*
Humans
Randomized Controlled Trials as Topic
Ursodeoxycholic Acid / therapeutic use*

Substances

Bile Acids and Salts
Cholagogues and Choleretics
Ursodeoxycholic Acid